{"id":"https://genegraph.clinicalgenome.org/r/4b8d340f-2003-43ba-b08c-dc7e05907428v2.0","type":"EvidenceStrengthAssertion","dc:description":"TNNC1 was first reported in relation to hypertrophic cardiomyopathy (HCM) in humans in 2001 (Hoffman et al, PMID 11385718). Over 21 probands in 12 publications have been published (Hoffman et al, 2001, PMID 11385718; Landstrom et al, 2008, PMID 18572189; Chung et al, 2011, PMID 21262074; Parvatiyar, 2012, PMID 22815480; Jaafar et al, 2015, PMID 26779504; Mademont-Soler I, et al., 2017, PMID: 28771489; Viswanathan SK, et al., 2017, PMID: 29121657; Robyns T, et al., 2017, PMID: 29255176; Jääskeläinen P, et al., 2019, PMID: 30775854; Cabrera Borrego E, et al., 2020, PMID: 34317385; Chung H, et al., 2021, PMID: 33658040; Alves-Pinto R, et al., 2022, PMID: 34488226). At least eleven unique heterozygous variants (10 missense, 1 truncating) with some evidence to support their pathogenicity and segregation in three families have been reported. One variant, p.Asn144Asp, has been seen 23 times in HCM probands with no other genetic cause, with segregation to 12 affected relatives (personal communication, Tomas Robyns UZ Leuven). The mechanism of disease is unknown. The gene-disease relationship is supported by in vitro functional studies, animal models, and interactions with TNNI3 and TNNT2. Variants in TNNC1 have also been reported in association with dilated cardiomyopathy (DCM), left ventricular noncompaction (LVNC), and restrictive cardiomyopathy (RCM). TNNC1 was shown to have a definitive gene-disease relationship with DCM by the ClinGen DCM Gene Curation Expert Pane (GCEP). The relationship of TNNC1 with LVNC and RCM has not been evaluated. The relationship between TNNC1 and autosomal dominant hypertrophic cardiomyopathy was originally evaluated by the ClinGen Hypertrophic Cardiomyopathy GCEP on November 1, 2016 and found to have a moderate classification. It was re-evaluated on September 13, 2023. As a result of this recuration, the classification changed from the original Moderate to Definitive.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4b8d340f-2003-43ba-b08c-dc7e05907428","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:newEvidence"},{"id":"cg:classificationChange"},{"id":"cg:expertPanelChange"},{"id":"cg:sopChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2023-09-13T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2023-10-10T21:28:49.014Z","role":"Publisher"}],"curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac4cff86-712b-462c-9746-6a6af7229736","type":"EvidenceLine","dc:description":"Patient also had other potentially causative variants in MYBPC3 (p.K814del) and MYH6. Absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac4cff86-712b-462c-9746-6a6af7229736_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/a630327a-e618-40c7-a7af-c839a11c6f7a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.354G>T (p.Lys118Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353165892"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1fec76ce-cea7-4468-9509-ada5c7e87327","type":"EvidenceLine","dc:description":"note - functional evidence is somewhat conflicting; not reported if case was genotyped for other potential causes of disease","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fec76ce-cea7-4468-9509-ada5c7e87327_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11385718","allele":{"id":"https://genegraph.clinicalgenome.org/r/256db776-2a4e-4fee-b1fa-1125eb3680a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.86T>A (p.Leu29Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122395"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/1fec76ce-cea7-4468-9509-ada5c7e87327_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Schmidtmann 2005, Baryshnikova 2008, Liang 2008, Dweck 2008, Neulen 2009, Parvatiyar 2012, Gollapudi 2012, Li 2013","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/70247555-2407-4906-bd8a-18203dbabb3c","type":"EvidenceLine","dc:description":"not enough data given to determine whether individual had other variants","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70247555-2407-4906-bd8a-18203dbabb3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32481709","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3ead359-38ce-401c-8bc3-9b2c0a5df3db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.430A>G (p.Asn144Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA297328"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c0348a61-1086-4ca7-8c38-93fc896489c0","type":"EvidenceLine","dc:description":"VUS in ClinVar, rare in gnomAD (two alleles, one Euro non-Finnish, one \"Other\"), no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0348a61-1086-4ca7-8c38-93fc896489c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29121657","allele":{"id":"https://genegraph.clinicalgenome.org/r/e08e1f72-8541-4d7e-a98c-276bead893eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.469A>C (p.Met157Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA297334"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b637ec70-6812-40c8-98d2-5b3fcd874e0c","type":"EvidenceLine","dc:description":"Truncating variant not expected to result in NMD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b637ec70-6812-40c8-98d2-5b3fcd874e0c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21262074","allele":{"id":"https://genegraph.clinicalgenome.org/r/01cabd36-d5ef-4a72-93cb-d3f8e1a9ad40","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.363dup (p.Gln122AlafsTer30)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA923726232"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3978fd2c-d659-4510-97b6-60cfda948e33","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3978fd2c-d659-4510-97b6-60cfda948e33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255176","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3ead359-38ce-401c-8bc3-9b2c0a5df3db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/89637cac-4f48-4de8-a673-996c1474a695","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89637cac-4f48-4de8-a673-996c1474a695_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30775854","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.23C>T (p.Ala8Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122397"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/89637cac-4f48-4de8-a673-996c1474a695_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"see other entries for this variant","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/032180a2-b47f-4161-a37c-7b8d02db613d","type":"EvidenceLine","dc:description":"No functional data. No entry in ClinVar. Absent from gnomAD. Patient had one additional variant, missense TTN","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/032180a2-b47f-4161-a37c-7b8d02db613d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/914e270c-e85f-4baf-abc6-73ba4074d9e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.214G>A (p.Val72Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353167589"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bf5b95d7-dfff-4955-827b-5d1c65025e34","type":"EvidenceLine","dc:description":"Functional evidence presented. Absent from gnomAD. No assertions from clinical labs in ClinVar","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf5b95d7-dfff-4955-827b-5d1c65025e34_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22815480","allele":{"id":"https://genegraph.clinicalgenome.org/r/73547fc2-3596-421f-90bb-7f3ee17742ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.91G>T (p.Ala31Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130608"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bf5b95d7-dfff-4955-827b-5d1c65025e34_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"variant results in Increased calcium sensitivity in cardiac skinned fibers, reconstituted actomyosin ATPase assays showed increased activation of the actomyosin ATPase (per this paper)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1d9ca89d-6ff5-4f95-9a94-d18fb9b04e39","type":"EvidenceLine","dc:description":"Functional evidence available, but unclear if it supports disease causation","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d9ca89d-6ff5-4f95-9a94-d18fb9b04e39_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18572189","allele":{"id":"https://genegraph.clinicalgenome.org/r/fef96900-9075-4b8d-bee8-ef7e0f674ffa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.402G>T (p.Glu134Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA134855"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/1d9ca89d-6ff5-4f95-9a94-d18fb9b04e39_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"\"Experimental studies have shown that this missense change does not exert the functional effect on calcium affinity that has been demonstrated for other TNNC1 variants (PMID: 18572189, 22489623, 19439414, 21056975)\"","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/515f6cef-8428-4010-9681-98d9490a195b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/515f6cef-8428-4010-9681-98d9490a195b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34317385","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/515f6cef-8428-4010-9681-98d9490a195b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Yes (see summaries for other pts with this variant)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8a077531-b83b-439a-9450-94c212c1a9ec","type":"EvidenceLine","dc:description":"Full genotyping details not available in paper","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a077531-b83b-439a-9450-94c212c1a9ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34488226","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8a077531-b83b-439a-9450-94c212c1a9ec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"see summaries for other pts with this variant","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7ea5d56f-9bc5-4371-9630-76759e84d7c0","type":"EvidenceLine","dc:description":"Also reported in patients with other phenotypes (DCM,LVNC), population frequency too high (gnomAD MAF (European Non-Finnish) 0.026%, overall 0.013%)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ea5d56f-9bc5-4371-9630-76759e84d7c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18572189","allele":{"id":"https://genegraph.clinicalgenome.org/r/88cbfe77-e0c6-4448-a95c-f80fe630362b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.435C>A (p.Asp145Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122401"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/7ea5d56f-9bc5-4371-9630-76759e84d7c0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"some functional data -  Increased forced development and recovery in pig cardiac skinned fibers, alters the response to protein-protein interactions within the cardiac troponin complex, alters response to strong cross-bridge binding (Landstrom 2008, Pinto et al., 2009; Swindle et al., 2010; Pinto et al., 2011","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7699e70a-0d39-4777-9df5-b3dfcc7fcf67","type":"EvidenceLine","dc:description":"Other variants: GLA Asp175Glu - VUS/LB in ClinVar, missense variant in TTN ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7699e70a-0d39-4777-9df5-b3dfcc7fcf67_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/d239cf5c-b051-4826-822d-39ed156fbffb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.121C>A (p.Leu41Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353168914"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/205e13e9-322f-4bdc-8b78-6bc1c59d54a3","type":"EvidenceLine","dc:description":"Individual also has pathogenic variant in TNNI3 (c.434G>A, p.Arg145Gln)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/205e13e9-322f-4bdc-8b78-6bc1c59d54a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33658040","allele":{"id":"https://genegraph.clinicalgenome.org/r/def05d0b-fcf2-456a-a37a-22ed4e356fbc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.304C>T (p.Arg102Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA297322"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7ac415aa-2ec0-4396-ad26-2c471301edf0","type":"EvidenceLine","dc:description":"No other causative variants reported in this individual. Absent from gnomAD. No ClinVar entry","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ac415aa-2ec0-4396-ad26-2c471301edf0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/d239cf5c-b051-4826-822d-39ed156fbffb"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/176d9fe3-ec72-41e7-be3c-342c7dbfefa2","type":"EvidenceLine","dc:description":"Not HCM phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/176d9fe3-ec72-41e7-be3c-342c7dbfefa2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30188508","allele":{"id":"https://genegraph.clinicalgenome.org/r/def05d0b-fcf2-456a-a37a-22ed4e356fbc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f16ebe61-8cc4-497c-925b-5eddef4d61ad","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f16ebe61-8cc4-497c-925b-5eddef4d61ad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33658040","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f16ebe61-8cc4-497c-925b-5eddef4d61ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"See other entries for this variant","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c715b42d-9d4e-4f37-b8b6-c159ae3ec166","type":"EvidenceLine","dc:description":"Not HCM phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c715b42d-9d4e-4f37-b8b6-c159ae3ec166_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30188508","allele":{"id":"https://genegraph.clinicalgenome.org/r/55ad8b4c-7549-466e-b1e7-525e40e7b7e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.243G>C (p.Met81Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2438545"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0411cfb1-361f-4f7e-bf2f-98a8ab497eaf","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0411cfb1-361f-4f7e-bf2f-98a8ab497eaf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255176","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3ead359-38ce-401c-8bc3-9b2c0a5df3db"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5b2f38d8-2907-49dd-8e05-74cc15865a32","type":"EvidenceLine","dc:description":"Absent from gnomAD. P/LP in ClinVar. Individual has additional variant in MYBPC3 c.3535G>A - benign or likely benign by most labs in ClinVar.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b2f38d8-2907-49dd-8e05-74cc15865a32_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/5b2f38d8-2907-49dd-8e05-74cc15865a32_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 18572189, 19439414, 21056975, 20459070, 22489623, 23425245, 26304555","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/003c4f6a-a298-4ea3-9f4f-c84433ab16db","type":"EvidenceLine","dc:description":"Functional data as above. P/LP in ClinVar. Patient had one additional variant - missense TTN","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/003c4f6a-a298-4ea3-9f4f-c84433ab16db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771489","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/003c4f6a-a298-4ea3-9f4f-c84433ab16db_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 18572189, 19439414, 21056975, 20459070, 22489623, 23425245, 26304555","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3ffa0e39-34ba-4727-902f-27bfca452e57","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ffa0e39-34ba-4727-902f-27bfca452e57_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26779504","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/3ffa0e39-34ba-4727-902f-27bfca452e57_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Knock-in mice exhibit HCM phenotype (Martins et al. 2015)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1f11c332-ec36-40a3-b376-c802dea4d7eb","type":"EvidenceLine","dc:description":"strong functional data, rare in gnomAD, P/LP in ClinVar","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f11c332-ec36-40a3-b376-c802dea4d7eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18572189","allele":{"id":"https://genegraph.clinicalgenome.org/r/94b45b89-db24-4374-b814-c40f838db351"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/1f11c332-ec36-40a3-b376-c802dea4d7eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"this paper and multiple others: PMID: 18572189, 19439414, 21056975, 20459070, 22489623, 23425245, 26304555","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2cfcb7b3-9d93-4ac9-bb92-5cea5451923a","type":"EvidenceLine","dc:description":"Not HCM phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cfcb7b3-9d93-4ac9-bb92-5cea5451923a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30188508","allele":{"id":"https://genegraph.clinicalgenome.org/r/28064b3d-1e9f-4c7b-baa0-9186f77fe75b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.281A>C (p.Glu94Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353167162"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4d318071-b2b9-41ea-92c2-19a1ed536745","type":"EvidenceLine","dc:description":"Functional evidence, absent from gnomAD; ClinVar - no assertions from clinical labs","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d318071-b2b9-41ea-92c2-19a1ed536745_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18572189","allele":{"id":"https://genegraph.clinicalgenome.org/r/d92d1bf5-f530-4c93-8d6a-f10d30f22ba8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003280.3(TNNC1):c.251G>A (p.Cys84Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA122399"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4d318071-b2b9-41ea-92c2-19a1ed536745_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"C84Y increases calcium sensitivity of ATPase activity and of force development. Only isolated protein shows a decrease of calcium affinitiy at the C-sites (summarized in Kalyva, 2014).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.8},{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28ecff45-f3e3-42a7-ab53-a67607344add","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7fd25289-b9c3-4d6c-a642-c247d731352b","type":"Finding","dc:description":"C terminus of cTnT directly interacts with cTnC and modulates myocardial force generation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31748410","rdfs:label":"Johnston Mass Spectroscopy","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0f477529-4138-40a5-9bb5-25c1d8f693e3","type":"EvidenceLine","dc:description":"Shown also in Lombardi 2008.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cb421a3-f9e3-4d92-a636-da1b5fe3547a","type":"Finding","dc:description":"cTNC-WT interacts with the non-phosphorylated N-terminal arm of cTnI (TNNI3) via peptide arrays and is abolished in the cTNC-L29Q mutation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16302972","rdfs:label":"Schmidtmann 2005 PI1","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b62dccdd-07a8-43e7-b8d9-1ea12ca876ba","type":"EvidenceLine","dc:description":"Similar results in Schmidtmann 2005.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4263da6f-9cc9-4768-8c59-e7e1f2b7a81b","type":"Finding","dc:description":"L29Q variant affects calcium kinetcs of TNNC1: L29Q decreased calcium sensitivity by 0.1 pCa units in a FRET calcium titration assay.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18063575","rdfs:label":"Dong 2008 Funct1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ac206258-5b3a-4414-b42e-5835262d5db8","type":"EvidenceLine","dc:description":"cTnI (147-163) is an important binding region for cNTnc, which binds in a calcium-dependent manner and relays the calcium signal. Calcium binding affinity of cNTnC is not affected by the N-terminal region of cTnI (unphosphorylated or phosophorylated).  L29Q affinity toward calcium is not changed (conflicting data?).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4014ff50-32ec-482c-9c2a-3bcc629f7433","type":"Finding","dc:description":"The affinities of cNTnC toward calcium and cTnI were measured in the presence of phosphorylated and unphosphorylated cTnI and how L29Q cNTnC affects binding was determined. The affinity of L29Q toward a region of cTnI (147-163) was perturbed.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18042489","rdfs:label":"Baryshnikova 2008 FunctAlt1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/868add80-4348-4e94-a632-5567ec147061","type":"EvidenceLine","dc:description":"Hindered transduction of phosphorylation signal?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e25fae4-a1e7-423a-9820-25f1f49ff94d","type":"Finding","dc:description":"A small reduction in calcium sensitivity was detected upon measuring calcium-dependent actoS1-ATPase activity and sliding velocity of thin filaments (CD spectroscopy). The max actoS1-ATPase activity (but not sliding velocity) was enhanced. This calcium sensitivity of actoS1-ATPase activity and mean sliding velocity were no longer affected by protein kinase-A-dependent phosphorylation of cTnI.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16302972","rdfs:label":"Schmidtmann 2005 Funct1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/99a61506-16b1-4e99-a898-6aeb562203b4","type":"EvidenceLine","dc:description":"Conflicts with Schmidtmann and Dong","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ac2a73f-55d3-4022-9a3f-b462851feaec","type":"Finding","dc:description":"L29Q variant signficantly increased calcium binding affinitity of cTnC. Fluorescense stop-flow technique also showed this. Force-pCa relationship determined that the mutant increased calcium sensitivity for force generation in skinned cardiac myocytes. Measured changes in length-dependent calcium sensitivity of single skinned cardiac myocytes reconstituted with L29Q variant and found that it was reduced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18285522","rdfs:label":"Liang 2008 FunctAlt1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25df6c87-247a-4d66-b6c2-2cd48e95ea10","type":"EvidenceLine","dc:description":"Possible that contractility is constantly above normal in hypertrophic hearts.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e638625d-0d2d-41c2-8ae8-d81b2d85f40f","type":"FunctionalAlteration","dc:description":"Muscle fibers reconstituted with A8V require 2.3 fold less calcium to achieve 50% maximum-tension compared to wild type. A8V also binds the switch-peptide of TnI 1.6 fold more strongly than wild type.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26976709","rdfs:label":"Zot 2016 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a04545d3-945c-4c0f-a35c-a60e39fa15b5","type":"EvidenceLine","dc:description":"Counted towards the variants under \"Case Data\" tab. 0 points fo E134D. 0 for C84Y. 0.5 points for A8V and D145E.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3bb5bdfb-58b2-4c0a-a028-b0a04d1b6b4f","type":"FunctionalAlteration","dc:description":"Calcium sensitivity of force development and force recovery were evaluated in cTnC-depleted, porcine cardiac skinned fibers reconstituted with mutants. A8V produced the largest shift from wildtype, followed by D145E and C84Y. E134D showed no difference. Force recovery was increased in fibers with A8V and D145E.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18572189","rdfs:label":"Landstrom 2008 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d5dce4f4-5195-4b96-9d74-de834cf99e49","type":"EvidenceLine","dc:description":"Triton-skinned myocardium preparations have no functional cell membranes or sarcoplasmic reticulum, but myofilamint lattice is intact.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/966e2132-cbb5-42b3-830d-5316f044e909","type":"FunctionalAlteration","dc:description":"Effect of L29Q on isometric force and unloaded shortening velocity in triton-skinned myocardium. Results showed no statistical significance.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19506933","rdfs:label":"Neulen 2009 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4d228290-a7d7-4eea-b5c7-0a060b8216a8","type":"EvidenceLine","dc:description":"Similar to Landstrom 2008. Don't count again.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c74d3e7b-426f-4915-ac16-2a3a9f528f5e","type":"FunctionalAlteration","dc:description":"Actomyosin ATPase and spectroscopic solution studies: A8V, C84Y and D145E increased calcium sensitivity of the myofilament. E134D was the same as WT. Only D145E showed increased ATPase activation in the presence of calcium.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19439414","rdfs:label":"Pinto 2009 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/309f1edb-2316-48e8-87c7-fb4a1abe569f","type":"EvidenceLine","dc:description":"Conflicting data again? This paper addresses more of a global change in myofilament dynamics.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d66b05a-e97d-4276-867e-665f08a14b58","type":"FunctionalAlteration","dc:description":"pCA-tension relationship and contractile dynamics in detergent-skinned rat cardiac papillary muscle fibers reconstituted with L29Q mutant showed decrease in calcium sensitivity and an increase in the rate of crossbridge (XB) recruitment dynamics.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23008774","rdfs:label":"Gallopudi 2012 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9753ac93-3e0f-49bd-b2a5-88455de6fb5e","type":"EvidenceLine","dc:description":"Counted towards the variant under \"Case Data\" tab.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/360ee6aa-d216-4189-acc7-3cc35f991ff3","type":"FunctionalAlteration","dc:description":"cTnc-A31S incorporated into cardiac porcine fibers resulted in an increase in calcium sensitivity, increase in activation of the actomyosin ATPase, and increase in calcium affinity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22815480","rdfs:label":"Parvatiyar 2012 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c59c7463-3803-4587-aaa7-fa00ea603669","type":"EvidenceLine","dc:description":"Consistent with Dweck's hypothesis that the calcium sensitizing effect of cTnC mutation is more pronounced in the presence of PKA-mediated phosphorylation of cTnI but is sarcomere length dependent.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ae0ddb1-b9b1-4800-886b-d47127cebb12","type":"FunctionalAlteration","dc:description":"\"The L29Q cTnC mutation decreased the Ca2+ binding affinity and enhanced the effects of pseudo-phosphorylation of cTnI in thin filament preparations but caused a small yet significant increase in Ca2+sensitivity of force and reduced the effects of pseudo-phosphorylation of cTnI in single SCM. More importantly, the effect of the L29Q cTnC mutation on Ca2+ sensitivity of force generation is extremely SL-dependent with the impact being maximal at the shorter SL (1.9 µm) and is virtually abolished at longer SL (2.3 µm).\"","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24260207","rdfs:label":"Li 2013 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/55828a3e-e9e2-4f2a-ae13-d1a22ec5ffb9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10951b62-15b4-4808-bda7-7c1caf7e6790","type":"FunctionalAlteration","dc:description":"NMR showed that the structure of cTnC was unchanged by L29Q but there was possibly a slight decrease in protein stability. In situ fluoresence from heart muscle cells showed that L29Q did not affect overall calcium sensitivity but decrease cooperativity. It also abolished the effect of force-generating cross-bridges on the calcium sensitivity of structural changes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26341255","rdfs:label":"Robertson FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e83fbbd0-8228-4112-acf7-be953c3f2c93","type":"EvidenceLine","dc:description":"Does this contradict Pinto 2009?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f06e074-6dda-446b-a7fa-1d9f8f36e57c","type":"FunctionalAlteration","dc:description":"Effect of A8V, E134D, and D145E on the properties of the C-domain sites (modulate the calcium signal). A8V had no effect, E134D moderately decreased calcium and magnesium binding affinities, and D145E reduced calcium binding affinity of both sites, III and IV, and also affected the interaction of the two sites.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20459070","rdfs:label":"Swindle 2010 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5147c02d-e04e-4d08-8513-1fd225e540cc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5416ef65-ac42-48aa-8271-bfd3b19e96a1","type":"FunctionalAlteration","dc:description":"Generated 20 new mutations in the non-calcium-liganding residues of cTnC (not yet found in patients) and looked for changes in calcium sensitivity of force development in cardiac skinned fibers. A23Q exhibited HCM-like properties: increased calcium sensitivity with normal levels of ATPase inhibition.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20566645","rdfs:label":"Parvatiyar 2010 FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5f053880-143d-4d3d-a50f-006800cc0b54","type":"EvidenceLine","dc:description":"Agrees with Neulen 2009.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93cd475e-1c35-41b2-82cd-be794a13339d","type":"FunctionalAlteration","dc:description":"L29Q effect on calcium sensitivity of tension and ATPase activity in skinned cardiac muscle cells: no effect under the conditions used.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18820258","rdfs:label":"Dweck 2008 FunctAtl1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cff3397a-e623-4b8a-a91f-fa23437ad6ee","type":"EvidenceLine","dc:description":"Similar to data that's already been shown? Don't count again?","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7f05abd-7631-4972-b4c1-0daf32988b7f","type":"FunctionalAlteration","dc:description":"A8V enhanced effect of cTnI pseudo-phosphorylation on the rate of calcium dissociation from reconsituted thin filaments and calcium dependence of actomyosin ATPase. E134D had no effect.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22489623","rdfs:label":"Albury FunctAlt1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5d832673-8acb-4a02-ae34-35e0d9981b70_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77bff8d2-e497-4d0f-8643-e3ab4b7ea3a6","type":"EvidenceLine","dc:description":"The A8V variant was found in a proband from Landstrom 2008 paper.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20612ad5-98a8-40ea-84ef-e215c4ded14b","type":"Finding","dc:description":"KI-TnC A8V mice developed mild to moderate left- and right- ventricular hypertrophy, hyperdynamic systolic function, and atrial enlargement. Changes in molecular mechanisms included altered calcium handling in cardiomyocytes and increased calcium sensitivity of contraction. Histopathology showed interstitial fibrosis, and myofibrillar dissarray also.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26304555","rdfs:label":"Martins Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1e969fb7-406f-49be-84f6-572cc91bc745","type":"EvidenceLine","dc:description":"TNNC1 is expressed in both cardiac and skeletal muscle, but duplicationin zebrafish has resulted in tissue specific expression. Tnnc1a is cardiac specific. Zebrafish is not an ideal animal model for HCM.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/242a061b-ec79-4b4a-afc3-f2ed19f4047e","type":"Finding","dc:description":"Characterization of a recessive embryonic lethal mutation in Tnnc1a: LoF results in defective heart contractility, abnormal atrial and ventricular chamber morphology, and loss of normal myofibrillar structure within sarcomeres.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20925115","rdfs:label":"Sogah 2010 Model1","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/793e96eb-8d09-4c87-88c0-6c101bf56031","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80c5a189-7912-4a6d-8bda-425b13fa146d","type":"Finding","dc:description":"Myocardial fibrosis, left ventricular hypertrophy, diastolic dysfunction all similar to HCM phenotype in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34163821","rdfs:label":"Marques mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":7063,"specifiedBy":"GeneValidityCriteria9","strengthScore":11.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ZG7W8c2XovI","type":"GeneValidityProposition","disease":"obo:MONDO_0005045","gene":"hgnc:11943","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5d832673-8acb-4a02-ae34-35e0d9981b70-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}